|
1
|
Ye EA and Steinle JJ: miR-146a attenuates
inflammatory pathways mediated by TLR4/NF-κB and TNFα to protect
primary human retinal microvascular endothelial cells grown in high
glucose. Mediators Inflamm. 2016:39584532016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Czajka AA, Wójcicka A, Kubiak A, Kotlarek
M, Bakuła-Zalewska E, Koperski Ł, Wiechno W and Jażdżewski K:
Family of microRNA-146 regulates RARβ in papillary thyroid
carcinoma. PLoS One. 11:e01519682016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Y, Zhang Q, Zhang HM, Liu W, Liu CJ,
Li Q and Guo AY: Transcription factor and miRNA co-regulatory
network reveals shared and specific regulators in the development
of B cell and T cell. Sci Rep. 5:152152015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H, Luo XQ, Zhang P, Huang LB, Zheng
YS, Wu J, Zhou H, Qu LH, Xu L and Chen YQ: MicroRNA patterns
associated with clinical prognostic parameters and CNS relapse
prediction in pediatric acute leukemia. PLoS One. 4:e78262009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adamaki M, Tsotra M, Vlahopoulos S,
Zampogiannis A, Papavassiliou AG and Moschovi M: STAT transcript
levels in childhood acute lymphoblastic leukemia: STAT1 and STAT3
transcript correlations. Leuk Res. Sep 11–2015.(Epub ahead of
print). View Article : Google Scholar
|
|
6
|
Lucas CM, Milani M, Butterworth M, Carmell
N, Scott LJ, Clark RE, Cohen GM and Varadarajan S: High CIP2A
levels correlate with an antiapoptotic phenotype that can be
overcome by targeting BCL-XL in chronic myeloid leukemia. Leukemia.
Feb 29–2016.(Epub ahead of print). View Article : Google Scholar
|
|
7
|
Xu L, Zhong H, Wan H, Chen FY, Zhong J,
Xiao F, Liu J and Shen L: miR-146a expression level as a novel
putative prognostic marker for acute promyelocytic leukemia. Dis
Markers. 2014:1506042014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Duyu M, Durmaz B, Gunduz C, Vergin C,
Karapinar D Yilmaz, Aksoylar S, Kavakli K, Cetingul N, Irken G,
Yaman Y, et al: Prospective evaluation of whole genome microRNA
expression profiling in childhood acute lymphoblastic leukemia.
Biomed Res Int. 2014:9675852014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saki N, Abroun S, Soleimani M, Mortazavi
Y, Kaviani S and Arefian E: The roles of miR-146a in the
differentiation of Jurkat T-lymphoblasts. Hematology. 19:141–147.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lionetti M, Musto P, Di Martino MT, Fabris
S, Agnelli L, Todoerti K, Tuana G, Mosca L, Cantafio ME Gallo,
Grieco V, et al: Biological and clinical relevance of miRNA
expression signatures in primary plasma cell leukemia. Clin Cancer
Res. 19:3130–3142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spinello I, Quaranta MT, Riccioni R, Riti
V, Pasquini L, Boe A, Pelosi E, Vitale A, Foà R, Testa U, et al:
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in
acute myeloid leukemias. Blood Cancer J. 1:e262011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao C, Wang W, Yu W, Jou D, Wang Y, Ma H,
Xiao H, Qin H, Zhang C, Lü J, et al: A novel small molecule STAT3
inhibitor, LY5, inhibits cell viability, colony formation, and
migration of colon and liver cancer cells. Oncotarget.
7:12917–12926. 2016.PubMed/NCBI
|
|
13
|
Midgley AC, Morris G, Phillips AO and
Steadman R: 17β-estradiol ameliorates age-associated loss of
fibroblast function by attenuating IFN-γ/STAT1-dependent miR-7
upregulation. Aging Cell. 15:531–541. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Legrier ME, Bièche I, Gaston J, Beurdeley
A, Yvonnet V, Déas O, Thuleau A, Château-Joubert S, Servely JL,
Vacher S, et al: Activation of IFN/STAT1 signalling predicts
response to chemotherapy in oestrogen receptor-negative breast
cancer. Br J Cancer. 114:177–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moles R, Bellon M and Nicot C: STAT1: A
novel target of miR-150 and miR-223 is involved in the
proliferation of HTLV-I-transformed and ATL cells. Neoplasia.
17:449–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu D, Han Q, Hou Z, Zhang C and Zhang J:
miR-146a negatively regulates NK cell functions via STAT1
signaling. Cell Mol Immunol. Mar 21–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
17
|
Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu
J, Shi L, Yang L, Ma Z, Chen L, et al: MicroRNA-146a feedback
suppresses T cell immune function by targeting Stat1 in patients
with chronic hepatitis B. J Immunol. 191:293–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kutty RK, Nagineni CN, Samuel W,
Vijayasarathy C, Jaworski C, Duncan T, Cameron JE, Flemington EK,
Hooks JJ and Redmond TM: Differential regulation of microRNA-146a
and microRNA-146b-5p in human retinal pigment epithelial cells by
interleukin-1β, tumor necrosis factor-α, and interferon-γ. Mol Vis.
19:737–750. 2013.PubMed/NCBI
|
|
19
|
Gény C, Rivière G, Bignon J, Birlirakis N,
Guittet E, Awang K, Litaudon M, Roussi F and Dumontet V: Anacardic
acids from Knema hookeriana as modulators of Bcl-xL/Bak and
Mcl-1/Bid interactions. J Nat Prod. 79:838–844. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarosiek KA and Letai A: Directly
targeting the mitochondrial pathway of apoptosis for cancer therapy
with BH3 mimetics: recent successes, current challenges and future
promise. FEBS J. Mar 21–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsumoto M, Nakajima W, Seike M, Gemma A
and Tanaka N: Cisplatin-induced apoptosis in non-small-cell lung
cancer cells is dependent on Bax- and Bak-induction pathway and
synergistically activated by BH3-mimetic ABT-263 in p53 wild-type
and mutant cells. Biochem Biophys Res Commun. 473:490–496. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hennessy EJ: Selective inhibitors of Bcl-2
and Bcl-xL: balancing antitumor activity with on-target toxicity.
Bioorg Med Chem Lett. 26:2105–2114. 2016. View Article : Google Scholar : PubMed/NCBI
|
